High expression of cell division cycle 7 protein correlates with poor prognosis in patients with diffuse large B-cell lymphoma
Medical Oncology, 04/30/2012
Hou Y et al. – The results suggest that CDC7 expression level in combination with International Prognostic Index (IPI) score and Ann Arbor stage can be specific prognostic factors for diffuse large B–cell lymphoma (DLBCL) patients. CDC7 could also be a potential therapeutic target in DLBCL, especially for ABC–DLBCL.



